These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 15188947
1. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study. Berman M, Erman A, Ben-Gal T, Dvir D, Georghiou GP, Stamler A, Vered Y, Vidne BA, Aravot D. Clin Cardiol; 2004 May; 27(5):295-9. PubMed ID: 15188947 [Abstract] [Full Text] [Related]
2. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study. Sinatra ST. Clin Cardiol; 2004 Oct; 27(10):A26; author reply A26, A30. PubMed ID: 15553298 [No Abstract] [Full Text] [Related]
3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G, Littarru GP, Q-SYMBIO Study Investigators. JACC Heart Fail; 2014 Dec; 2(6):641-9. PubMed ID: 25282031 [Abstract] [Full Text] [Related]
4. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial. Mortensen AL, Rosenfeldt F, Filipiak KJ. Cardiol J; 2019 Dec; 26(2):147-156. PubMed ID: 30835327 [Abstract] [Full Text] [Related]
5. Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"--a multinational trial. Mortensen SA. Biofactors; 2003 Dec; 18(1-4):79-89. PubMed ID: 14695923 [Abstract] [Full Text] [Related]
6. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group. Hofman-Bang C, Rehnqvist N, Swedberg K, Wiklund I, Aström H. J Card Fail; 1995 Mar; 1(2):101-7. PubMed ID: 9420639 [Abstract] [Full Text] [Related]
7. Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose. Pierce JD, Mahoney DE, Hiebert JB, Thimmesch AR, Diaz FJ, Smith C, Shen Q, Mudaranthakam DP, Clancy RL. BMC Cardiovasc Disord; 2018 Apr 02; 18(1):57. PubMed ID: 29606104 [Abstract] [Full Text] [Related]
8. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials. Lei L, Liu Y. BMC Cardiovasc Disord; 2017 Jul 24; 17(1):196. PubMed ID: 28738783 [Abstract] [Full Text] [Related]
9. Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure. Mortensen SA, Vadhanavikit S, Baandrup U, Folkers K. Drugs Exp Clin Res; 1985 Jul 24; 11(8):581-93. PubMed ID: 3836876 [Abstract] [Full Text] [Related]
10. The effect of coenzyme Q10 in patients with congestive heart failure. Khatta M, Alexander BS, Krichten CM, Fisher ML, Freudenberger R, Robinson SW, Gottlieb SS. Ann Intern Med; 2000 Apr 18; 132(8):636-40. PubMed ID: 10766682 [Abstract] [Full Text] [Related]
11. Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Samuel TY, Hasin T, Gotsman I, Weitzman T, Ben Ivgi F, Dadon Z, Asher E, Amir O, Glikson M, Alcalai R, Leibowitz D. Drugs R D; 2022 Mar 18; 22(1):25-33. PubMed ID: 34826125 [Abstract] [Full Text] [Related]
12. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study. Morisco C, Trimarco B, Condorelli M. Clin Investig; 1993 Mar 18; 71(8 Suppl):S134-6. PubMed ID: 8241697 [Abstract] [Full Text] [Related]
13. Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant. Folkers K, Langsjoen P, Langsjoen PH. Biochem Biophys Res Commun; 1992 Jan 15; 182(1):247-53. PubMed ID: 1731784 [Abstract] [Full Text] [Related]
15. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Rosenfeldt F, Hilton D, Pepe S, Krum H. Biofactors; 2003 Jan 15; 18(1-4):91-100. PubMed ID: 14695924 [Abstract] [Full Text] [Related]
16. Refractory congestive heart failure successfully managed with high dose coenzyme Q10 administration. Sinatra ST. Mol Aspects Med; 1997 Jan 15; 18 Suppl():S299-305. PubMed ID: 9266540 [Abstract] [Full Text] [Related]
17. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10. Langsjoen PH, Vadhanavikit S, Folkers K. Proc Natl Acad Sci U S A; 1985 Jun 15; 82(12):4240-4. PubMed ID: 3858877 [Abstract] [Full Text] [Related]
18. [Coenzyme Q10 (ubiquinone) in the treatment of heart failure. Are any positive effects documented?]. Spigset O. Tidsskr Nor Laegeforen; 1994 Mar 20; 114(8):939-42. PubMed ID: 8191473 [Abstract] [Full Text] [Related]
19. Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure (interim analysis). The CoQ10 Drug Surveillance Investigators. Baggio E, Gandini R, Plancher AC, Passeri M, Carmosino G. Clin Investig; 1993 Mar 20; 71(8 Suppl):S145-9. PubMed ID: 8241700 [Abstract] [Full Text] [Related]
20. Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment. Morisco C, Nappi A, Argenziano L, Sarno D, Fonatana D, Imbriaco M, Nicolai E, Romano M, Rosiello G, Cuocolo A. Mol Aspects Med; 1994 Mar 20; 15 Suppl():s155-63. PubMed ID: 7752827 [Abstract] [Full Text] [Related] Page: [Next] [New Search]